These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 2003855)
21. Hylan G-F 20 maintains cartilage integrity and decreases osteophyte formation in osteoarthritis through both anabolic and anti-catabolic mechanisms. Li P; Raitcheva D; Hawes M; Moran N; Yu X; Wang F; Matthews GL Osteoarthritis Cartilage; 2012 Nov; 20(11):1336-46. PubMed ID: 22809835 [TBL] [Abstract][Full Text] [Related]
22. The in vivo effects of intraarticular corticosteroid injections on cartilage lesions, stromelysin, interleukin-1, and oncogene protein synthesis in experimental osteoarthritis. Pelletier JP; DiBattista JA; Raynauld JP; Wilhelm S; Martel-Pelletier J Lab Invest; 1995 May; 72(5):578-86. PubMed ID: 7745952 [TBL] [Abstract][Full Text] [Related]
23. [The dose dependent effect of glycosaminoglycan peptide complex on corticosteroid-induced disordered metabolism in cartilage tissue of rats]. Annefeld M Z Rheumatol; 1989; 48(4):188-93. PubMed ID: 2800736 [TBL] [Abstract][Full Text] [Related]
24. Danshen prevents articular cartilage degeneration via antioxidation in rabbits with osteoarthritis. Bai B; Li Y Osteoarthritis Cartilage; 2016 Mar; 24(3):514-20. PubMed ID: 26485068 [TBL] [Abstract][Full Text] [Related]
25. Nonsteroidal antiinflammatory drugs in treatment of osteoarthritis. Brandt KD; Slowman-Kovacs S Clin Orthop Relat Res; 1986 Dec; (213):84-91. PubMed ID: 3780106 [TBL] [Abstract][Full Text] [Related]
26. Selective COX-2 inhibition is favorable to human early and late-stage osteoarthritic cartilage: a human in vitro study. Mastbergen SC; Bijlsma JW; Lafeber FP Osteoarthritis Cartilage; 2005 Jun; 13(6):519-26. PubMed ID: 15922186 [TBL] [Abstract][Full Text] [Related]
28. A Novel Synthesized Sulfonamido-Based Gallate-JEZTC Blocks Cartilage Degradation on Rabbit Model of Osteoarthritis: An in Vitro and in Vivo Study. Lu Z; Liu Q; Liu L; Wu H; Zheng L; Zhao JM Cell Physiol Biochem; 2018; 49(6):2304-2319. PubMed ID: 30261492 [TBL] [Abstract][Full Text] [Related]
29. A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models. Baragi VM; Becher G; Bendele AM; Biesinger R; Bluhm H; Boer J; Deng H; Dodd R; Essers M; Feuerstein T; Gallagher BM; Gege C; Hochgürtel M; Hofmann M; Jaworski A; Jin L; Kiely A; Korniski B; Kroth H; Nix D; Nolte B; Piecha D; Powers TS; Richter F; Schneider M; Steeneck C; Sucholeiki I; Taveras A; Timmermann A; Van Veldhuizen J; Weik J; Wu X; Xia B Arthritis Rheum; 2009 Jul; 60(7):2008-18. PubMed ID: 19565489 [TBL] [Abstract][Full Text] [Related]
30. Study of the effect of a glycosaminoglycan-peptide complex on the degradative enzyme activities in human osteoarthritic cartilage. Vignon E; Martin A; Mathieu P; Conrozier T; Louisot P; Richard M Clin Rheumatol; 1990 Sep; 9(3):383-8. PubMed ID: 2261738 [TBL] [Abstract][Full Text] [Related]
31. The effects of carboxymethylated chitosan on metalloproteinase-1, -3 and tissue inhibitor of metalloproteinase-1 gene expression in cartilage of experimental osteoarthritis. Liu SQ; Qiu B; Chen LY; Peng H; Du YM Rheumatol Int; 2005 Nov; 26(1):52-7. PubMed ID: 15765218 [TBL] [Abstract][Full Text] [Related]
32. Cartilage degradative enzymes in human osteoarthritis: effect of a nonsteroidal antiinflammatory drug administered orally. Vignon E; Mathieu P; Broquet P; Louisot P; Richard M Semin Arthritis Rheum; 1990 Feb; 19(4 Suppl 1):26-9. PubMed ID: 2315705 [TBL] [Abstract][Full Text] [Related]
33. Effect of oral glucosamine on cartilage degradation in a rabbit model of osteoarthritis. Tiraloche G; Girard C; Chouinard L; Sampalis J; Moquin L; Ionescu M; Reiner A; Poole AR; Laverty S Arthritis Rheum; 2005 Apr; 52(4):1118-28. PubMed ID: 15818693 [TBL] [Abstract][Full Text] [Related]
34. Efficacy and tolerability of galactosamino-glycuronoglycan-sulfate in osteoarthritis of the knee: an 11-month experience. Chevallard M; Galanti A; Paresce E; Wolf A; Carrabba M Int J Clin Pharmacol Res; 1993; 13 Suppl():49-53. PubMed ID: 7995682 [TBL] [Abstract][Full Text] [Related]
35. Effects of tenoxicam and aspirin on the metabolism of proteoglycans and hyaluronan in normal and osteoarthritic human articular cartilage. Manicourt DH; Druetz-Van Egeren A; Haazen L; Nagant de Deuxchaisnes C Br J Pharmacol; 1994 Dec; 113(4):1113-20. PubMed ID: 7889262 [TBL] [Abstract][Full Text] [Related]
36. Molecular regulation of articular chondrocyte function and its significance in osteoarthritis. Schroeppel JP; Crist JD; Anderson HC; Wang J Histol Histopathol; 2011 Mar; 26(3):377-94. PubMed ID: 21210351 [TBL] [Abstract][Full Text] [Related]
37. Effects of low molecular weight hyaluronan combined with carprofen on canine osteoarthritis articular chondrocytes and cartilage explants in vitro. Euppayo T; Siengdee P; Buddhachat K; Pradit W; Viriyakhasem N; Chomdej S; Ongchai S; Harada Y; Nganvongpanit K In Vitro Cell Dev Biol Anim; 2015 Sep; 51(8):857-65. PubMed ID: 25982358 [TBL] [Abstract][Full Text] [Related]
39. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1). Dahlberg L; Billinghurst RC; Manner P; Nelson F; Webb G; Ionescu M; Reiner A; Tanzer M; Zukor D; Chen J; van Wart HE; Poole AR Arthritis Rheum; 2000 Mar; 43(3):673-82. PubMed ID: 10728762 [TBL] [Abstract][Full Text] [Related]
40. Study of an inhibitor of plasminogen activator (tranexamic acid) in the treatment of experimental osteoarthritis. Vignon E; Mathieu P; Bejui J; Descotes J; Hartmann D; Patricot LM; Richard M J Rheumatol Suppl; 1991 Feb; 27():131-3. PubMed ID: 1851228 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]